Nanoviricides (NNVC) Preferred Shares (2011 - 2026)
Nanoviricides (NNVC) posted Preferred Shares of $9.0 for Q1 2026, little changed sequentially from $9.0 in Q4 2025, and little changed YoY from $9.0 in Q1 2025.
Nanoviricides (NNVC) Preferred Shares (2011 - 2026) Analysis & Trends
Nanoviricides has reported Preferred Shares for 16 years, with the latest figure at $9.0 in Q1 2026.
- Quarterly Preferred Shares changed 0.0% year-over-year to $9.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 (changed 0.0% YoY) and the FY2025 annual result came in at $9.0, changed 0.0% from the prior year.
- Preferred Shares held at $9.0 in Q1 2026 per NNVC's latest filing, from $9.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $497.0 in Q1 2023 and troughed at $5.0 in Q2 2023.
- A 5-year average of $150.35 and a median of $9.0 in 2023 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2023 and 2024: Preferred Shares tumbled 98.99% in 2023, then surged 80.0% in 2024.
- Over 5 years, Preferred Shares stood at $495.0 in 2022, then plunged by 98.18% to $9.0 in 2023, then changed by 0.0% to $9.0 in 2024, then changed by 0.0% to $9.0 in 2025, then changed by 0.0% to $9.0 in 2026.
- According to Business Quant data, Preferred Shares over the past three periods registered $9.0, $9.0, and $9.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Nanoviricides | 29.82 Mn | 26.61 Mn | - | 9.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 |
| Dec 31, 2025 | 9.00 |
| Sep 30, 2025 | 9.00 |
| Jun 30, 2025 | 9.00 |
| Mar 31, 2025 | 9.00 |
| Dec 31, 2024 | 9.00 |
| Sep 30, 2024 | 9.00 |
| Jun 30, 2024 | 9.00 |
| Mar 31, 2024 | 9.00 |
| Dec 31, 2023 | 9.00 |
| Sep 30, 2023 | 5.00 |
| Jun 30, 2023 | 5.00 |
| Mar 31, 2023 | 497.00 |
| Dec 31, 2022 | 495.00 |
| Sep 30, 2022 | 495.00 |
| Jun 30, 2022 | 485.00 |
| Mar 31, 2022 | 484.00 |
| Dec 31, 2021 | 482.00 |
| Sep 30, 2021 | 482.00 |
| Jun 30, 2021 | 372.00 |